Zacks: Analysts Anticipate UnitedHealth Group Incorporated (UNH) Will Post Earnings of $2.50 Per Share
Wall Street analysts expect UnitedHealth Group Incorporated (NYSE:UNH) to report earnings per share of $2.50 for the current fiscal quarter, Zacks Investment Research reports. Five analysts have provided estimates for UnitedHealth Group’s earnings. The highest EPS estimate is $2.53 and the lowest is $2.46. UnitedHealth Group posted earnings of $2.11 per share in the same quarter last year, which would suggest a positive year over year growth rate of 18.5%. The business is scheduled to announce its next earnings report on Tuesday, January 16th.
According to Zacks, analysts expect that UnitedHealth Group will report full year earnings of $9.99 per share for the current fiscal year, with EPS estimates ranging from $9.95 to $10.02. For the next fiscal year, analysts anticipate that the company will post earnings of $10.81 per share, with EPS estimates ranging from $10.65 to $10.90. Zacks’ earnings per share averages are a mean average based on a survey of research analysts that cover UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. The firm had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the business posted $2.17 earnings per share.
UnitedHealth Group (NYSE:UNH) traded down $0.28 during trading hours on Wednesday, reaching $222.49. 2,294,100 shares of the company’s stock traded hands, compared to its average volume of 3,100,740. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The firm has a market cap of $215,879.17, a price-to-earnings ratio of 23.20, a price-to-earnings-growth ratio of 1.65 and a beta of 0.66. UnitedHealth Group has a 12 month low of $156.09 and a 12 month high of $231.77.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were issued a $0.75 dividend. The ex-dividend date was Thursday, November 30th. This represents a $3.00 annualized dividend and a dividend yield of 1.35%. UnitedHealth Group’s dividend payout ratio is currently 33.26%.
In related news, Director Kenneth Irwin Shine sold 457 shares of the company’s stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Larry C. Renfro sold 50,574 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the sale, the insider now directly owns 195,625 shares in the company, valued at $38,755,268.75. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 62,606 shares of company stock worth $12,677,525. Company insiders own 0.89% of the company’s stock.
A number of institutional investors and hedge funds have recently made changes to their positions in UNH. Marshall Wace LLP boosted its stake in UnitedHealth Group by 441.4% during the 2nd quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock worth $2,578,000 after purchasing an additional 11,361 shares during the period. American Century Companies Inc. boosted its stake in UnitedHealth Group by 16.9% during the 2nd quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after purchasing an additional 681,111 shares during the period. Schwab Charles Investment Management Inc. boosted its stake in UnitedHealth Group by 5.3% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock worth $678,077,000 after purchasing an additional 183,401 shares during the period. Essex Financial Services Inc. boosted its stake in UnitedHealth Group by 12.3% during the 2nd quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock worth $1,640,000 after purchasing an additional 967 shares during the period. Finally, Factory Mutual Insurance Co. boosted its stake in UnitedHealth Group by 20.9% during the 2nd quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock worth $77,245,000 after purchasing an additional 72,000 shares during the period. 86.20% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: “Zacks: Analysts Anticipate UnitedHealth Group Incorporated (UNH) Will Post Earnings of $2.50 Per Share” was first reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://www.americanbankingnews.com/2017/12/13/zacks-analysts-anticipate-unitedhealth-group-incorporated-unh-will-post-earnings-of-2-50-per-share.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.